RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Reverse Warburg Effect-Related Mitochondrial Activity and 18F-FDG Uptake in Invasive Ductal Carcinoma

      한글로보기

      https://www.riss.kr/link?id=A106474175

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose We evaluated the relationship between fluorine-18 fluoro-2-deoxy-glucose (18F-FDG) uptake and mitochondrial activity in cancer cells and investigated the prognostic implications of this relationship in patients with invasive ductal carcinoma of the breast (IDCB).
      Methods One hundred forty-six patients with primary IDCB who underwent preoperative 18F-FDG PET/CT followed by curative surgical resection were enrolled in the current study. Mitochondrial activity of cancer cells was assessed based on translocase of outer mitochondrial membrane 20 (TOMM20) expression and cytochrome C oxidase (COX) activity. A Pearson’s correlation analysis was used to assess the relationship between the maximum standardized uptake value of the primary tumour (pSUVmax) and mitochondrial activity. Clinicopathological factors, including pSUVmax, histological grade, oestrogen receptor (ER), progesterone receptor (PR), and TOMM20 expression; and COX activity, were assessed for the prediction of disease-free survival (DFS) using the Kaplan–Meier method and Cox proportional hazards model.
      Results Fourteen of the 146 subjects (9.6%) showed tumour recurrence. There was a significant positive correlation between 18F-FDG uptake and the mitochondrial activity of cancer cells in patients with IDCB, and increased 18F-FDG uptake and mitochondrial activity were significantly associated with a shorter DFS. Additionally, results from the receiver-operating curve analysis demonstrated that the cut-off values of pSUVmax, TOMM20 expression, and COX activity for the prediction of DFS were 7.76, 4, and 5, respectively. Further, results from the univariate analysis revealed that pSUVmax, TOMM20 expression, PR status, and histologic grade were significantly associated with DFS; however, the multivariate analysis revealed that only pSUVmax was associated with DFS (HR, 6.51; 95% CI, 1.91, 22.20; P = 0.003).
      Conclusions The assessment of preoperative 18F-FDG uptake and post-surgical mitochondrial activity may be used for the prediction of DFS in patients with IDCB.
      번역하기

      Purpose We evaluated the relationship between fluorine-18 fluoro-2-deoxy-glucose (18F-FDG) uptake and mitochondrial activity in cancer cells and investigated the prognostic implications of this relationship in patients with invasive ductal carcinoma o...

      Purpose We evaluated the relationship between fluorine-18 fluoro-2-deoxy-glucose (18F-FDG) uptake and mitochondrial activity in cancer cells and investigated the prognostic implications of this relationship in patients with invasive ductal carcinoma of the breast (IDCB).
      Methods One hundred forty-six patients with primary IDCB who underwent preoperative 18F-FDG PET/CT followed by curative surgical resection were enrolled in the current study. Mitochondrial activity of cancer cells was assessed based on translocase of outer mitochondrial membrane 20 (TOMM20) expression and cytochrome C oxidase (COX) activity. A Pearson’s correlation analysis was used to assess the relationship between the maximum standardized uptake value of the primary tumour (pSUVmax) and mitochondrial activity. Clinicopathological factors, including pSUVmax, histological grade, oestrogen receptor (ER), progesterone receptor (PR), and TOMM20 expression; and COX activity, were assessed for the prediction of disease-free survival (DFS) using the Kaplan–Meier method and Cox proportional hazards model.
      Results Fourteen of the 146 subjects (9.6%) showed tumour recurrence. There was a significant positive correlation between 18F-FDG uptake and the mitochondrial activity of cancer cells in patients with IDCB, and increased 18F-FDG uptake and mitochondrial activity were significantly associated with a shorter DFS. Additionally, results from the receiver-operating curve analysis demonstrated that the cut-off values of pSUVmax, TOMM20 expression, and COX activity for the prediction of DFS were 7.76, 4, and 5, respectively. Further, results from the univariate analysis revealed that pSUVmax, TOMM20 expression, PR status, and histologic grade were significantly associated with DFS; however, the multivariate analysis revealed that only pSUVmax was associated with DFS (HR, 6.51; 95% CI, 1.91, 22.20; P = 0.003).
      Conclusions The assessment of preoperative 18F-FDG uptake and post-surgical mitochondrial activity may be used for the prediction of DFS in patients with IDCB.

      더보기

      참고문헌 (Reference)

      1 Aogi K, "Utility of 18F FDG-PET/CT for predicting prognosis of luminal-type breast cancer" 150 : 209-217, 2015

      2 Witkiewicz AK, "Using the"reverse Warburg effect"to identify high-risk breast cancer patients : stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers" 11 : 1108-1117, 2012

      3 Vander Heiden MG, "Understanding theWarburg effect : the metabolic requirements of cell proliferation" 324 : 1029-1033, 2009

      4 Sotgia F, "Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment" 13 : 213-, 2011

      5 Fu Y, "The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy" 8 : 57813-57825, 2017

      6 Pavlides S, "The reverse Warburg effect : aerobic glycolysis in cancer associated fibroblasts and the tumor stroma" 8 : 3984-4001, 2009

      7 Ullah MS, "The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism" 281 : 9030-9037, 2006

      8 Warburg O, "The metabolism of carcinoma cells" 9 : 148-163, 1925

      9 Eheman CR, "The changing incidence of in situ and invasive ductal and lobular breast carcinomas : United States, 1999-2004" 18 : 1763-1769, 2009

      10 Sonveaux P, "Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice" 118 : 3930-3942, 2008

      1 Aogi K, "Utility of 18F FDG-PET/CT for predicting prognosis of luminal-type breast cancer" 150 : 209-217, 2015

      2 Witkiewicz AK, "Using the"reverse Warburg effect"to identify high-risk breast cancer patients : stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers" 11 : 1108-1117, 2012

      3 Vander Heiden MG, "Understanding theWarburg effect : the metabolic requirements of cell proliferation" 324 : 1029-1033, 2009

      4 Sotgia F, "Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment" 13 : 213-, 2011

      5 Fu Y, "The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy" 8 : 57813-57825, 2017

      6 Pavlides S, "The reverse Warburg effect : aerobic glycolysis in cancer associated fibroblasts and the tumor stroma" 8 : 3984-4001, 2009

      7 Ullah MS, "The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism" 281 : 9030-9037, 2006

      8 Warburg O, "The metabolism of carcinoma cells" 9 : 148-163, 1925

      9 Eheman CR, "The changing incidence of in situ and invasive ductal and lobular breast carcinomas : United States, 1999-2004" 18 : 1763-1769, 2009

      10 Sonveaux P, "Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice" 118 : 3930-3942, 2008

      11 Doherty JR, "Targeting lactate metabolism for cancer therapeutics" 123 : 3685-3692, 2013

      12 Kadoya T, "Role ofmaximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer : a multiinstitute study" 141 : 269-275, 2013

      13 Grover-McKay M, "Role for glucose transporter 1 protein in human breast cancer" 4 : 115-120, 1998

      14 Bovenzi CD, "Prognostic indications of elevated MCT4 and CD147 across cancer types : a meta-analysis" 2015 : 242437-, 2015

      15 Groheux D, "Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer" 42 : 377-385, 2015

      16 Caroline Kampf, "Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas" MyJove Corporation (63) : 2012

      17 Martinez-Outschoorn UE, "Power surge : supporting cells"fuel"cancer cell mitochondria" 15 : 4-5, 2012

      18 Warburg O, "On the origin of cancer cells" 123 : 309-314, 1956

      19 Wurm CA, "Nanoscale distribution of mitochondrial import receptor Tom20 is adjusted to cellular conditions and exhibits an innercellular gradient" 108 : 13546-13551, 2011

      20 García Vicente AM, "Molecular subtypes of breast cancer : metabolic correlation with 18F-FDG PET/CT" 40 : 1304-1311, 2013

      21 Koit A, "Mitochondrial respiration in human colorectal and breast cancer clinical material is regulated differently" 2017 : 1372640-, 2017

      22 Porporato PE, "Mitochondrial metabolism and cancer" 28 : 265-280, 2018

      23 Sotgia F, "Mitochondria"fuel"breast cancer metabolism : fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells" 11 : 4390-4401, 2012

      24 Bellance N, "Mitochondria : from bioenergetics to the metabolic regulation of carcinogenesis" 14 : 4015-4034, 2009

      25 Caro P, "Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma" 22 : 547-560, 2012

      26 Hensley CT, "Metabolic heterogeneity in human lung tumors" 164 : 681-694, 2016

      27 Kaambre T, "Metabolic control analysis of cellular respiration in situ in intraoperational samples of human breast cancer" 44 : 539-558, 2012

      28 Lester SC, "Members of the Cancer Committee, College of American Pathologies. Protocol for the examination of specimens from patients with invasive carcinoma of the breast" 133 : 1515-1538, 2009

      29 Johnson JM, "MCT1 in invasive ductal carcinoma : monocarboxylate metabolism and aggressive breast cancer" 5 : 27-, 2017

      30 Whitaker-Menezes D, "Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ : visualizing the therapeutic effects ofmetformin in tumor tissue" 10 : 4047-4064, 2011

      31 Huebbers CU, "High glucose uptake unexpectedly is accompanied by high levels of themitochondrial ß-F1-ATPase subunit in head and neck squamous cell carcinoma" 6 : 36172-36184, 2015

      32 DeBerardinis RJ, "Fundamentals of cancer metabolism" 2 : e1600200-, 2016

      33 Whitaker-Menezes D, "Evidence for a stromalepithelial"lactate shuttle"in human tumors : MCT4 is a marker of oxidative stress in cancer-associated fibroblasts" 10 : 1772-1783, 2011

      34 Jeong YJ, "Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT" 20 : 32-38, 2017

      35 Ekmekcioglu O, "Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma" 34 : 1055-1067, 2013

      36 Ueda S, "Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging(18F-FDG PET/CT)in primary breast cancer" 38 : 250-258, 2008

      37 DeNicola GM, "Cancer’s fuel choice : new flavors for a picky eater" 60 : 514-523, 2015

      38 Siegel RL, "Cancer statistics, 2019" 69 : 7-34, 2019

      39 Curry JM, "Cancer metabolism, stemness and tumor recurrence : MCT1 andMCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer" 12 : 1371-1384, 2013

      40 Danhier P, "Cancer metabolism in space and time : beyond the Warburg effect" 1858 : 556-572, 2017

      41 Martinez-Outschoorn UE, "Cancer cells metabolically"fertilize"the tumor microenvironment with hydrogen peroxide, driving the Warburg effect : implications for PET imaging of human tumors" 10 : 2504-2520, 2011

      42 García Vicente AM, "Basal 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer" 42 : 1804-1813, 2015

      43 Fang S, "Advances in glucose metabolism research in colorectal cancer" 5 : 289-295, 2016

      44 Caresia Aroztegui AP, "18F-FDG PET/CT in breast cancer : evidence-based recommendations in initial staging" 39 : 1010428317728285-, 2017

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2016-12-26 학술지명변경 한글명 : Nuclear Medicine and Molecular Imaging -> Nuclear Medicine and Molecular Imaging
      외국어명 : 미등록 -> Nuclear Medicine and Molecular Imaging
      KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2010-03-12 학술지명변경 한글명 : 핵의학 분자영상 -> Nuclear Medicine and Molecular Imaging KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.06 0.06 0.06
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.09 0.08 0.275 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼